EMD SERONO, INC. for EMD SERONO INC
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.R. 3: Lower Drug Costs Now Act of 2019; all provisions of the bill H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions of the bill H.R. 1035: Prescription Drug Price Transparency Act; all provisions of the bill H.R. 2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act; all provisions of the bill H.R. 2296: More Efficient Tools to Realize Information for Consumers (MICRA) Act; all provisions of the bill S. 102: Prescription Drug Price Relief Act of 2019; all provisions of the bill S. 340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions of the bill S. 447: Keep Americans Safe Act; all provisions of the bill S. 474: Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019; all provisions of the bill S. 1209: Reforming Evergreening and Manipulation that Extends Drug Years Act; all provisions of the bill S. 1391: Fair Accountability and Innovative Research Drug Pricing Act of 2019; all provisions of the bill S. 1416 - Affordable Prescriptions for Patients Act of 2019; all provisions of the bill S. 1895: Lower Health Care Costs Act; all provisions of the bill S. 2543: Prescription Drug Pricing Reduction Act of 2019; all provisions of the bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
| THOMAS CORDREY ROBERGE | — |
| WENDY SUSSMAN | — |
Chemicals/Chemical Industry CHM
General discussions regarding the 2020 National Defense Authorization Act and PFAs/PFOS chemicals General discussions regarding the Chemical Facility Anti-Terrorism Standards Act reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Tariff (miscellaneous tariff bills) TAR
General discussions regarding the 2020 Miscellaneous Tariff Bill (MTB) process
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Medical/Disease Research/Clinical Labs MED
General discussions regarding Predictive Toxicology Roadmap
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Animals ANI
General discussions regarding Predictive Toxicology Roadmap
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Trade (domestic/foreign) TRD
General discussions regarding United States-Switzerland Trade Agreement General discussions regarding United States-Mexico-Canada Agreement (USMCA) General discussions regarding China Section 301 tariffs and product exclusions
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Taxation/Internal Revenue Code TAX
General discussions regarding the repeal of Internal Revenue Code Section 385 regulations
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Copyright/Patent/Trademark CPT
S. 1209: Reforming Evergreening and Manipulation that Extends Drug Years Act; all provisions of the bill S. 1416: Affordable Prescriptions for Patients Act of 2019; all provisions of the bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
| THOMAS CORDREY ROBERGE | — |
| WENDY SUSSMAN | — |
Health Issues HCR
H.R. 3: Lower Drug Costs Now Act of 2019; all provisions of the bill H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions of the bill H.R. 1046: Medicare Negotiation and Competitive Licensing Act of 2019; all provisions of the bill H.R. 2113: Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act; all provisions of the bill H.R. 2296: More Efficient Tools to Realize Information for Consumers (METRIC) Act; all provisions of the bill S. 102: Prescription Drug Price Relief Act of 2019; all provisions of the bill S. 340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions of the bill S. 377: Medicare Negotiation and Competitive Licensing Act of 2019; all provisions of the bill S. 447: Keep Americans Safe Act; all provisions of the bill S. 1895: Lower Health Care Costs Act; all provisions of the bill S. 2543: Prescription Drug Pricing Reduction Act of 2019; all provisions of the bill General discussions regarding support for, and importance of, care giving
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
| THOMAS CORDREY ROBERGE | — |
| WENDY SUSSMAN | — |
Medicare/Medicaid MMM
H.R. 3: Lower Drug Costs Now Act of 2019; all provisions of the bill H.R. 1046: Medicare Negotiation and Competitive Licensing Act of 2019; all provisions of the bill S. 102: Prescription Drug Price Relief Act of 2019; all provisions of the bill S. 377: Medicare Negotiation and Competitive Licensing Act of 2019; all provisions of the bill S. 1391: Fair Accountability and Innovative Research Drug Pricing Act of 2019; all provisions of the bill S. 2543: Prescription Drug Pricing Reduction Act of 2019; all provisions of the bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
| THOMAS CORDREY ROBERGE | — |
| WENDY SUSSMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.